{"id":4823,"date":"2018-07-20T16:54:19","date_gmt":"2018-07-20T16:54:19","guid":{"rendered":"http:\/\/41j.com\/blog\/?p=4823"},"modified":"2018-07-20T16:54:19","modified_gmt":"2018-07-20T16:54:19","slug":"bgi-miscellany","status":"publish","type":"post","link":"https:\/\/41j.com\/blog\/2018\/07\/bgi-miscellany\/","title":{"rendered":"BGI &#8211; Miscellany"},"content":{"rendered":"<p>I&#8217;ve previous discussed the <a href=\"http:\/\/41j.com\/blog\/2018\/07\/bgi-part-1-business\/\">BGI Business<\/a>, and the DNA sequencing technology they <a href=\"http:\/\/41j.com\/blog\/2018\/07\/bgi-complete-genomics\/\">acquired from Complete Genomics<\/a>. In this post I want to tie up a few loose ends. In particular, I was curious to see if the BGIs patents covered any other approaches. From what I can tell, their patents don&#8217;t cover other approaches in much depth, but there are a few interesting bits and bobs!<\/p>\n<h2>MGI Tech<\/h2>\n<p>MGI Technologies is a wholly owned subsidiary of the BGI Group. They&#8217;re currently looking to IPO on the Hong Kong stock exchange, and are attempting to raise 1B USD [2]. They have a number of patents assigned to them, these mostly concern themselves with sample prep methods. However there is one patent on DNA sequencer chip design [3] it looks very much like the BGISEQ50 chip shown on one of their <a href=\"http:\/\/www.seq500.com\">sites<\/a>:<\/p>\n<p><a href=\"http:\/\/41j.com\/blog\/2018\/07\/bgi-miscellany\/chip-4\/\" rel=\"attachment wp-att-4824\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-4824\" src=\"http:\/\/41j.com\/blog\/wp-content\/uploads\/2018\/07\/chip.png\" alt=\"\" width=\"397\" height=\"259\" \/><\/a><\/p>\n<h2>SBS-patent?<\/h2>\n<p>There&#8217;s a patent from the BGI which seems a bit odd to me [5]. It essentially seems to cover a flowcell and SBS sequencing methodology that looks very much like the Illumina process. In fact, the flowcells look almost identical:<\/p>\n<div id=\"attachment_4827\" style=\"width: 408px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/41j.com\/blog\/2018\/07\/bgi-miscellany\/chip_bgi_ilm\/\" rel=\"attachment wp-att-4827\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-4827\" class=\"wp-image-4827\" src=\"http:\/\/41j.com\/blog\/wp-content\/uploads\/2018\/07\/chip_bgi_ilm.png\" alt=\"\" width=\"398\" height=\"160\" \/><\/a><p id=\"caption-attachment-4827\" class=\"wp-caption-text\">Chip from BGI patent&#8230;<\/p><\/div>\n<p>&nbsp;<\/p>\n<div id=\"attachment_4825\" style=\"width: 384px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/41j.com\/blog\/2018\/07\/bgi-miscellany\/highoutput-final\/\" rel=\"attachment wp-att-4825\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-4825\" class=\"wp-image-4825\" src=\"http:\/\/41j.com\/blog\/wp-content\/uploads\/2018\/07\/HighOutput-final.jpg\" alt=\"\" width=\"374\" height=\"148\" \/><\/a><p id=\"caption-attachment-4825\" class=\"wp-caption-text\">Example Hiseq flowcell from [4].<\/p><\/div>\n<p>&nbsp;<\/p>\n<p>It&#8217;s possible that there&#8217;s something I&#8217;m missing here, because the patent is in Chinese, and the translation isn&#8217;t great. But it&#8217;s interesting none the less. The patent doesn&#8217;t seem to cover specifics of the chemistry or imaging system, but seems to talk about the overall approach. MGI Tech also seem to have a patent covering a 2 color optical system [7], not dissimilar to the Illumina 2 color sequencing approach.<\/p>\n<p>A number of other patents cover optical systems for DNA sequencers, but don&#8217;t appear to discuss a particular sequencing approach [6].<\/p>\n<h2>Nanopore Patent<\/h2>\n<p>There&#8217;s one nanopore patent [1] assigned to the BGI Shenzhen. It mostly concerns itself with a &#8220;multi-pass sequencing&#8221; approach, to reduce error rates. In this approach a &#8220;concatemer nucleic acid molecule comprising a plurality of copies of the target sequence&#8221; is used to reduce the overall error rate.<\/p>\n<p>The patent also discusses &#8220;membranes of randomly distributed nanopores&#8221; as opposed to ordered arrays used in most systems. They suggest that nanopores are instead randomly distributed on a single membrane. Optionally they can be cross-linked to fix them in place. Micro-pipettes are then are then used to create a seal around one side of the nanopore. This is similar to a traditional patch-clamp approach, and I don&#8217;t quite understand what they&#8217;re getting at here. It seems like they suggesting billions of pipettes are used. This seems like a problematic system to build.<\/p>\n<p>&nbsp;<\/p>\n<h2>Notes<\/h2>\n<p>[1] Nanopore methods patent http:\/\/www.freepatentsonline.com\/WO2016077313A1.pdf<\/p>\n<p>[2] https:\/\/www.bloomberg.com\/news\/articles\/2018-04-25\/china-dna-giant-s-equipment-arm-said-to-seek-1-billion-funding<\/p>\n<p>[3] Chip design: http:\/\/www.freepatentsonline.com\/WO2018081920A1.pdf<\/p>\n<p>[4] https:\/\/www.utsouthwestern.edu\/labs\/next-generation-sequencing-core\/sequencing\/<\/p>\n<p>[5] https:\/\/patentimages.storage.googleapis.com\/9d\/a9\/9c\/697f0ed8d84cab\/CN205133580U.pdf another patent, https:\/\/patentimages.storage.googleapis.com\/8a\/13\/0b\/727f18776a8f2e\/CN205368331U.pdf also describes a 2 lane flowcell.<\/p>\n<p>[6] https:\/\/patents.google.com\/patent\/CN205368376U<\/p>\n<p>[7] https:\/\/patents.google.com\/patent\/CN206607236U<\/p>\n","protected":false},"excerpt":{"rendered":"<p>I&#8217;ve previous discussed the BGI Business, and the DNA sequencing technology they acquired from Complete Genomics. In this post I want to tie up a few loose ends. In particular, I was curious to see if the BGIs patents covered any other approaches. From what I can tell, their patents don&#8217;t cover other approaches in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[],"class_list":["post-4823","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p1RRoU-1fN","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/41j.com\/blog\/wp-json\/wp\/v2\/posts\/4823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/41j.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/41j.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/41j.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/41j.com\/blog\/wp-json\/wp\/v2\/comments?post=4823"}],"version-history":[{"count":5,"href":"https:\/\/41j.com\/blog\/wp-json\/wp\/v2\/posts\/4823\/revisions"}],"predecessor-version":[{"id":4832,"href":"https:\/\/41j.com\/blog\/wp-json\/wp\/v2\/posts\/4823\/revisions\/4832"}],"wp:attachment":[{"href":"https:\/\/41j.com\/blog\/wp-json\/wp\/v2\/media?parent=4823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/41j.com\/blog\/wp-json\/wp\/v2\/categories?post=4823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/41j.com\/blog\/wp-json\/wp\/v2\/tags?post=4823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}